Éva Nagy

Title: Éva Nagy: Innovator in Viral Vector Technology

Introduction

Éva Nagy is a prominent inventor based in Guelph, Canada. He has made significant contributions to the field of viral vector technology, particularly in the development of non-pathogenic strains of fowl adenovirus. His work has implications for immunogenic compositions and disease prevention.

Latest Patents

Éva Nagy holds a patent for a non-pathogenic serotype 4 fowl adenovirus (FAdV-4) and its viral vector. This high-level replication fowl adenovirus isolate is capable of reaching a viral titer of at least 3 log 10. The strain, identified as FAdV-4 ON1, is designed to be non-pathogenic. The patent also includes a viral vector that incorporates an exogenous nucleotide sequence coding for at least one antigenic site of a disease of concern. Additionally, it outlines a method for obtaining the viral vector and an immunogenic composition that includes it.

Career Highlights

Éva Nagy has established himself as a key figure in the field of virology through his innovative research and patent contributions. His work at the University of Guelph has positioned him as a leader in the development of viral vectors for medical applications.

Collaborations

Éva has collaborated with notable colleagues, including Bryan Griffin and Helena Grgic, to advance research in viral vector technology. Their combined expertise has contributed to the success of various projects and innovations.

Conclusion

Éva Nagy is a distinguished inventor whose work in viral vector technology has the potential to impact disease prevention and immunology significantly. His contributions continue to shape the future of virology and medical research.